Dr. Kimberly M. Desantis, MD
Family Medicine (Family Medicine Physician)
- Medicare participating
At a glance
- Medical school
- State University of New York at Buffalo School of Medicine (1996)
- Years since graduation
- 30
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 223
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1996Medical school: State University of New York at Buffalo School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Medicine Physician primary
NY license 211449
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- United Health Services Hospitals, Inc Binghamton, NY
- Our Lady of Lourdes Memorial Hospital, Inc Binghamton, NY
- Chenango Memorial Hospital Norwich, NY
Medical groups
- Endwell Family Physicians LLP (26 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 223
- Services billed
- 2,888
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 389 | 157 |
| Insertion of needle into vein for collection of blood sample | 326 | 148 |
| Blood test, comprehensive group of blood chemicals | 206 | 140 |
| Blood test, lipids (cholesterol and triglycerides) | 189 | 133 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 150 | 113 |
| Established patient office or other outpatient visit, 20-29 minutes | 113 | 83 |
| Hemoglobin a1c level | 90 | 49 |
| Blood test, thyroid stimulating hormone (tsh) | 83 | 54 |
| Administration of influenza virus vaccine | 71 | 71 |
| Influenza vaccine split virus, preservative free | 65 | 65 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 47 payments worth $769 in total to this clinician.
| AbbVie Inc. | $193 |
|---|---|
| Novo Nordisk Inc | $189 |
| Amgen Inc. | $81.54 |
| Phathom Pharmaceuticals, Inc. | $69.64 |
| Lilly USA, LLC | $52.10 |
| GlaxoSmithKline, LLC. | $36.41 |
| Iti, Inc. (d/b/a Intra-cellular Therapies, Inc.) | $30.62 |
| Pfizer Inc. | $27.02 |
| Food and Beverage | $769 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $34,487 in research payments for these studies, mostly to the institutions running them.
- A phase 3 study to evaluate the efficacy immunogenicity and safety of respiratory syncytial virus rsv prefusion f subunit vaccine in adults
Pfizer Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.